Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

NCT00203463 is registered in ClinicalTrials.gov with Tuscaloosa Research & Education Advancement Corporation as lead sponsor.

NCT NCT00203463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
Lead sponsor
Tuscaloosa Research & Education Advancement Corporation
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2001
Completion date
September 30, 2004
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd